Jushi: Canaccord Raises Estimates Following Nature’s Remedy Acquisition

On September 13th, Jushi Holdings (CSE: JUSH) announced that they completed their acquisition of Nature’s Remedy for a slightly reduced $91.2 in million total consideration, instead of the original $100 million agreed upon. The company reduced the number of shares issued to 8.7 million instead of the original 11.9 million, but increased the debt component to $16.50 million.

Nature’s Remedy has a 50,000 square foot cultivation and production facility, with a 22,000 square foot “high-quality” indoor production and “state-of-the-art extraction” facility. The company expects to expand that to 32,500 square feet by the end of this year. They also operate 2 retail dispensaries.

Jushi Holdings currently has 6 analysts covering the stock with an average 12-month price target of $12.14, or a 143% upside. Out of the 6 analysts, 2 have strong buy ratings and 4 have buy ratings. The street high sits at $14 from PI Financial and the lowest comes in at $10.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Canaccord Genuity reiterated their U$8/C$10 price target and Buy rating on the stock after the news dropped. Bobby Burleson, Canaccord’s analyst, says, “With the ability to walk away based on original deal terms, management was able to negotiate a lower price and receive roughly $20m in flower inventory to boot.” The price of the deal now sits at sub 2.5x 2022 EBITDA.

With the close, Canaccord has elected to raise their full year 2021 and 2022 estimates slightly but are keeping their third quarter estimate the same.

They add that the cultivation assets acquired come with additional room for expansion, with the operation producing 16,000 pounds of biomass and 9,000 pounds of high-quality cannabis annually currently. Jushi expects to bring this number up to 26,000 pounds and 13,000 pounds, respectively. The facility is located within a 185,000 square foot complex, “which presents numerous expansion opportunities and could potentially accommodate up to an additional 18,000 to 20,000 square feet of canopy.”

Canaccord calls the two dispensaries acquired strong retail locations in “strategic locations.” with one located along the “Worcester-Providence Turnpike and is in close proximity to the Shoppes at Blackstone Valley, Central Massachusetts’s largest open-air shopping center.” While the other location is located near the Pheasant Lane Mall, which is one of the largest malls in New Hampshire.

Below you can see Canaccord’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Copper Mine Costs 1/6 to Restart | SSR Mining X Roxmore

Why Cambria Hit Pause on Its Massive Copper-Gold Spinout

Can Gold Rescue Washington From Its Debt Trap? | Andy Schectman – Miles Franklin

Recommended

Mercado Minerals Lengthens El Triunfo Vein by 190 Metres, Readies 1,500-Metre Zamora Drill Program

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Related News

First Quantum: BMO Lowers Target To $32 After Guidance Issuance

On January 17th, First Quantum Minerals (TSX: FM) announced its 2021 preliminary production and 2022...

Wednesday, January 19, 2022, 04:29:00 PM

Walt Disney: Analysts Anticipate $15.87 Billion In Q2 Revenue

Walt Disney (NYSE: DIS) will be reporting their fiscal second-quarter financial results today after market...

Thursday, May 13, 2021, 02:20:00 PM

Li-Cycle: BMO Cuts Target After Negative Revenues Recorded In Q3

Li-Cycle (NYSE: LICY) recently reported its third-quarter financial results. The company reported revenues of -$2...

Sunday, September 25, 2022, 11:13:00 AM

Topaz Energy Sees BMO Resume Analyst Coverage

On June 8th, Topaz Energy Corp. (TSX: TPZ) had a flurry of news releases. The...

Friday, June 11, 2021, 04:16:00 PM

Well Health: PI Financial Raises Price Target To $7.00 On Back Of Circle Acquisition

This week WELL Health Technologies (TSX: WELL) announced that they are expanding into the US...

Friday, September 4, 2020, 01:38:00 PM